Biological activities of a new steroidal inhibitor of delta 4-5 alpha-reductase.
D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000378:metabolism*; D058891:5-alpha Reductase Inhibitors; D000818:Animals; D001378:Azasteroids / Q000378:metabolism / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects; D013196:Dihydrotestosterone / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004970:Estrone / Q000494:pharmacology; D005260:Female; D005262:Feminization / Q000139:chemically induced; D005298:Fertility / Q000187:drug effects; D005485:Flutamide / Q000494:pharmacology; D008297:Male; D009929:Organ Size / Q000187:drug effects; D010053:Ovary / Q000033:anatomy & histology / Q000187:drug effects; D010088:Oxidoreductases / Q000378:metabolism*; D011388:Prolactin / Q000097:blood; D011467:Prostate / Q000033:anatomy & histology / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D012669:Seminal Vesicles / Q000033:anatomy & histology / Q000187:drug effects; D013260:Steroids, Heterocyclic / Q000494:pharmacology*; D014599:Uterus / Q000033:anatomy & histology / Q000187:drug effects
D058891:5-alpha Reductase Inhibitors; D001378:Azasteroids; D013260:Steroids, Heterocyclic; D013196:Dihydrotestosterone; D004970:Estrone; C031563:17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one; D005485:Flutamide; D011388:Prolactin; D010088:Oxidoreductases; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase